Cargando…
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
BACKGROUND: Aspirin and omega-3 fatty acids (FAs) have potential disease-modifying roles in diabetic retinopathy (DR) and age-related macular degeneration (AMD), but randomized evidence of these effects is limited. We present the rationale and baseline characteristics of ASCEND-Eye, a sub-study of t...
Autores principales: | Sammons, Emily, Bowman, Louise, Stevens, William, Buck, Georgina, Wallendszus, Karl, Hammami, Imen, Parish, Sarah, Armitage, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517364/ https://www.ncbi.nlm.nih.gov/pubmed/37745288 http://dx.doi.org/10.1016/j.conctc.2023.101184 |
Ejemplares similares
-
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
por: Parish, Sarah, et al.
Publicado: (2022) -
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
por: Bowman, Louise, et al.
Publicado: (2018) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
por: Parish, Sarah, et al.
Publicado: (2023) -
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial–Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial
por: Harper, Charlie, et al.
Publicado: (2021) -
Enron Ascending
por: Bradley, Robert
Publicado: (2018)